MedLife Medical System has completed the acquisition of Veridia Medical Center
Buharest, March 5, 2021: MedLife Medical System announces the completion of the transaction for the purchase of the full shareholding package of Veridia Medical Center in Bucharest, known as Basarab Medical Center.
Veridia Medical Center has been operating on the private medical services market for 17 years, being a traditional player in Bucharest. It has started its activity with a medical analysis laboratory and later on consolidated its position by developing a large medical center that incorporates 20 medical offices and which provides specialized medical services, general medicine consultations and consultations of different specialties, paraclinical investigations, treatments and minor surgeries. Additionally, for sampling for laboratory testing, the center also includes four sampling points, located in Berceni, Militari, Drumul Taberei and Pantelimon neighborhoods.
Since the beginning of September 2020, Veridia Medical Center, through the molecular biology laboratory, is in partnership with the Directorate of Public Health (DSP) for RT-PCR testing, designed to detect SARS-CoV-2 virus, with a capacity of 400 samples per day.
At the same time, Veridia is one of the relevant providers of medical services under contract with the Health Insurance House of Bucharest (CASMB), covering over 25 specialties, including allergology, ENT, endocrinology, obstetrics-gynecology, pediatrics, cardiology, pneumology, gastroenterology and neurology. For the corporate segment, the medical center plays an important role, as it provides occupational health services to companies.
MedLife is the largest provider of private healthcare services in Romania. The company operates the largest network of clinics, one of the largest networks of medical laboratories, mono and multidisciplinary hospitals and has the largest customer base for Health Prevention Packages in the country. It is also one of the largest private healthcare providers in Central and Eastern Europe in terms of sales.
The shares issued by MedLife SA are admitted to trading on the regulated spot market administered by the Bucharest Stock Exchange, Premium Category, with the trading symbol ″ M ″.
MedLife Group has a succesflul history in terms of both organic growth and growth by acquisitions. Since 2009 it has opened or acquired more than 150 medical units. Strong and experienced management team, has been able to create and manage these growth opportunities, gaining valuable knowledge and experience that will support the group to successfully continue the expansion.